http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101948816-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 |
| filingDate | 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101948816-B1 |
| titleOfInvention | Composition for simultaneous detection of hepatitis b virus (hbv) and lamivudine-resistant hbv |
| abstract | The present invention relates to a composition for simultaneously detecting HBV and lamivudine-resistant HBV comprising a primer and a probe specifically binding to HBV gene and lamivudine resistant HBV gene, a kit comprising the same, and a method for detecting HBV and lamivudine resistant HBV using the same The composition for simultaneous detection of HBV and lamivudine resistant HBV according to the present invention can detect HBV and lamivudine resistant HBV simultaneously using specific DNA primers and probes and PNA probes, And to provide information that can recommend drug conversion early, thereby reducing the cost of patient treatment and tracking patients. |
| priorityDate | 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.